''I'm certain Nina and team have made it clear a while ago to all interested parties (and there are a few) that Dimerix intend to take DMX-200 until at least Phase 3 interim readout before agreeing to any licencing agreement.''
Yep...with that kind of thinking ( and it doesn't come as a surprise at all) it's little wonder the stock is in the toilet
'' Interested parties'' is the most overused term in biotech.....it's a throwaway line
Someone who asks you for your business card at a conference can now suddenly become '' an interested party''
Ann: Successful Completion of DSMB Review of Phase 3 FSGS Trial, page-31
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $247.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.8¢ | 43.8¢ | $701.3K | 1.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111371 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8072 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |